ALTU-135 Completed Phase 3 Trials for Cystic Fibrosis (CF) / Exocrine Pancreatic Insufficiency Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Open-Label Phase III Long-Term Safety Trial of Liprotamase
https://clinicaltrials.gov/ct2/show/Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency